Global Genetic Testing Market Research Report 2012-2024

Table of Contents

1 Market Overview

• 1.1 Objectives of Research
  • 1.1.1 Definition
  • 1.1.2 Specifications
• 1.2 Market Segment
  • 1.2.1 by Type
    • 1.2.1.1 Newborn Screening
    • 1.2.1.2 Diagnostic Testing
    • 1.2.1.3 Carrier Testing
    • 1.2.1.4 Preimplantation Genetic Diagnosis
    • 1.2.1.5 Prenatal Diagnosis
    • 1.2.1.6 Predictive and Presymptomatic Testing
    • 1.2.1.7 Pharmacogenomics
  • 1.2.2 by Application
    • 1.2.2.1 Cardiology
    • 1.2.2.2 Dermatology
    • 1.2.2.3 Hematology
    • 1.2.2.4 Hereditary Cancer
    • 1.2.2.5 Immunology
    • 1.2.2.6 Metabolic Disorders and Newborn Screening
    • 1.2.2.7 Neurology
    • 1.2.2.8 Ophthalmology
    • 1.2.2.9 Pediatric Genetics
    • 1.2.2.10 Others
  • 1.2.3 by Regions

2 Industry Chain

• 2.1 Industry Chain Structure
• 2.2 Upstream
• 2.3 Market
  • 2.3.1 SWOT
  • 2.3.2 Dynamics

3 Environmental Analysis

• 3.1 Policy
• 3.2 Economic
• 3.3 Technology
• 3.4 Market Entry

4 Market Segmentation by Type

• 4.1 Market Size
  • 4.1.1 Newborn Screening Market, 2013-2018
  • 4.1.2 Diagnostic Testing Market, 2013-2018
  • 4.1.3 Carrier Testing Market, 2013-2018
  • 4.1.4 Preimplantation Genetic Diagnosis Market, 2013-2018
  • 4.1.5 Prenatal Diagnosis Market, 2013-2018
  • 4.1.6 Predictive and Presymptomatic Testing Market, 2013-2018
  • 4.1.7 Pharmacogenomics Market, 2013-2018
• 4.2 Market Forecast
  • 4.2.1 Newborn Screening Market Forecast, 2019-2024
  • 4.2.2 Diagnostic Testing Market Forecast, 2019-2024
  • 4.2.3 Carrier Testing Market Forecast, 2019-2024
  • 4.2.4 Preimplantation Genetic Diagnosis Market Forecast, 2019-2024
  • 4.2.5 Prenatal Diagnosis Market Forecast, 2019-2024
  • 4.2.6 Predictive and Presymptomatic Testing Market Forecast, 2019-2024
  • 4.2.7 Pharmacogenomics Market Forecast, 2019-2024

5 Market Segmentation by Application

• 5.1 Market Size
  • 5.1.1 Cardiology Market, 2013-2018
  • 5.1.2 Dermatology Market, 2013-2018
  • 5.1.3 Hematology Market, 2013-2018
  • 5.1.4 Hereditary Cancer Market, 2013-2018
  • 5.1.5 Immunology Market, 2013-2018
  • 5.1.6 Metabolic Disorders and Newborn Screening Market, 2013-2018
  • 5.1.7 Neurology Market, 2013-2018
  • 5.1.8 Ophthalmology Market, 2013-2018
  • 5.1.9 Pediatric Genetics Market, 2013-2018
  • 5.1.10 Others Market, 2013-2018
• 5.2 Market Forecast
  • 5.2.1 Cardiology Market Forecast, 2019-2024
  • 5.2.2 Dermatology Market Forecast, 2019-2024
  • 5.2.3 Hematology Market Forecast, 2019-2024
  • 5.2.4 Hereditary Cancer Market Forecast, 2019-2024
  • 5.2.5 Immunology Market Forecast, 2019-2024
  • 5.2.6 Metabolic Disorders and Newborn Screening Market Forecast, 2019-2024
  • 5.2.7 Neurology Market Forecast, 2019-2024
  • 5.2.8 Ophthalmology Market Forecast, 2019-2024
  • 5.2.9 Pediatric Genetics Market Forecast, 2019-2024
  • 5.2.10 Others Market Forecast, 2019-2024

6 Market Segmentation by Region

• 6.1 Market Size
  • 6.1.1 Asia-Pacific
    • 6.1.1.1 Asia-Pacific Market, 2012-2018
    • 6.1.1.2 Asia-Pacific Market by Type
    • 6.1.1.3 Asia-Pacific Market by Application
  • 6.1.2 North America
    • 6.1.2.1 North America Market, 2012-2018
    • 6.1.2.2 North America Market by Type
    • 6.1.2.3 North America Market by Application
  • 6.1.3 Europe
    • 6.1.3.1 Europe Market, 2012-2018
    • 6.1.3.2 Europe Market by Type
    • 6.1.3.3 Europe Market by Application
  • 6.1.4 South America
    • 6.1.4.1 South America Market, 2012-2018
    • 6.1.4.2 South America Market by Type
    • 6.1.4.3 South America Market by Application
  • 6.1.5 Middle East & Africa
    • 6.1.5.1 Middle East & Africa Market, 2012-2018
    • 6.1.5.2 Middle East & Africa Market by Type
    • 6.1.5.3 Middle East & Africa Market by Application
• 6.2 Market Forecast
  • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
  • 6.2.2 North America Market Forecast, 2019-2024
  • 6.2.3 Europe Market Forecast, 2019-2024
  • 6.2.4 South America Market Forecast, 2019-2024
  • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 Market Competitive

• 7.1 Global Market by Vendors
• 7.2 Market Concentration
• 7.3 Price & Factors
• 7.4 Marketing Channel

8 Major Vendors

• 8.1 GeneDx
• 8.2 Invitae
• 8.3 Pathway Genomics
• 8.4 Counsyl Inc
• 8.5 Asper Biotech
• 8.6 GenePlanet
• 8.7 Courtagen Life Sciences
• 8.8 Gene By Gene
• 8.9 Natera Inc
• 8.10 Regulatory
• 8.11 GeneTests
• 8.12 United Gene
• 8.13 HI Gene
• 8.14 Berry Genomics
• 8.15 23andMe Inc
• 8.16 360Jiyin
• 8.17 Novogene
• 8.18 CapitalBio
• 8.19 Agen
• 8.20 Biomedlab
• 8.21 Biomarker
• 8.22 Annoroad
• 8.23 Aiyin Gene
• 8.24 Aijiyin
• 8.25 Repconex
• 8.26 Find Bio-Tech
• 8.27 SinoGenoMax
• 8.28 Gene Kang
• 8.29 Geeppine
• 8.30 BGI

9 Conclusion